| Autor: |
Lin JHX; Diabetes and Diabetic Foot, King's College NHS Foundation Trust, London, UK.; Department of Medicine, Woodlands Health, Singapore., Papanas N; Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece., Zayed H; Vascular Surgical Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK., Vas PRJ; Diabetes and Diabetic Foot, King's College NHS Foundation Trust, London, UK.; King's College London, UK.; King's Health Partners' Institute of Diabetes, Endocrinology and Obesity, London, UK. |
| Jazyk: |
angličtina |
| Zdroj: |
The international journal of lower extremity wounds [Int J Low Extrem Wounds] 2023 Jul 18, pp. 15347346231188874. Date of Electronic Publication: 2023 Jul 18. |
| DOI: |
10.1177/15347346231188874 |
| Abstrakt: |
Chronic limb-threatening ischaemia (CLTI) is a severe form of peripheral arterial disease (PAD) and is associated with an increased risk of amputation, mortality, and significantly impaired quality of life. International guidelines recommend considering timely revascularisation and optimal medical therapy to improve limb perfusion in individuals with CLTI. The 2 primary revascularization approaches for CLTI are open bypass surgery (BS) and endovascular therapy (EV), however, there is currently no consensus on the best initial treatment strategy for CLTI, leading to uncertainty among clinicians. To shed light on this issue, 2 recent trials, namely best endovascular versus best surgical therapy in patients with CLI (BEST-CLI) and bypass versus angioplasty for severe ischaemia of the leg (BASIL-2), have tried to provide valuable insights. While a definitive conclusion on the optimal revascularisation approach is still pending, these trials offer immediate and clinically relevant information to the diabetic foot multidisciplinary team. The trials encompassed a distinct range of patient cohorts and included participants with varying degrees of medical and physical frailty. Taken together, their findings, highlight the need for an individualised revascularisation strategy which accounts for underlying comorbidities, risk factors, disease severity, availability of suitable bypass conduits, surgical risks, and timely access to procedures. Regardless of the chosen strategy, early referral of patients with diabetes and CLTI to a specialist team within a multidisciplinary environment is crucial. Comprehensive care should encompass essential elements such as adequate debridement, infection control, offloading, glycaemic control, smoking cessation, and patient education. By addressing these aspects, healthcare providers can optimise the management and outcomes for individuals with CLTI and diabetes. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
